Sentences with phrase «big cap biotechs»

Big cap biotechs like Biogen, Celgene, and others are all down anywhere from 2 % to 3.5 %.

Not exact matches

What Stephen Hawking Missed: Small Biotechs Developing Promising Cell Therapies for Devastating Disease Source: Streetwise Reports (5/2/18) In the second of a two - part series exploring the disruptive cell therapy space, Maxim Group analyst Jason McCarthy takes a look at small - cap companies targeting big - ticket indications and their potential to drive blockbuster value for both patients and investors.

No. 3: The year of big pharma In the past five years, big cap pharmaceutical stocks have lagged biotech stocks because they've struggled to fill revenue gaps created by the patent cliff.

Even after breaking out of a seven - month base at 25.88 in big volume on Nov. 6 and quadrupling in price, the market value of the developer of treatments that are commercialized by its Big Pharma and biotech partners is $ 17 billion, a far cry from the megacaps such as Amgen (AMGN)($ 136 billion market cap) or Gilead Sciences (GILD)($ 106 billiobig volume on Nov. 6 and quadrupling in price, the market value of the developer of treatments that are commercialized by its Big Pharma and biotech partners is $ 17 billion, a far cry from the megacaps such as Amgen (AMGN)($ 136 billion market cap) or Gilead Sciences (GILD)($ 106 billioBig Pharma and biotech partners is $ 17 billion, a far cry from the megacaps such as Amgen (AMGN)($ 136 billion market cap) or Gilead Sciences (GILD)($ 106 billion).